Oral Abstract Session:
215. Translating Microbiome Science into Practice
Saturday, October 6, 2018: 10:30 AM-11:45 AM
Room: W 2002

Tracks: Adult ID, Investigative ID, Pediatric ID, Trainee


Moderators:  Vincent B. Young, MD, PhD, FIDSA, University of Michigan and Marcia Goldberg, MD, FIDSA, Massachusetts General Hospital

Presentations:
10:30 AM
Gut Resistome Changes in Response to Prophylactic Antibiotic Administration During Chemotherapy in Children with Acute Lymphoblastic Leukemia
Ellie Margolis, MD PhD; Hana Hakim, MD, MS; Jiangwei Yao, PhD; Jason Rosch, PhD; Li Tang, PhD; Yilun Sun, MS; Ronald Dallas, PhD; Joshua Wolf, MBBS FRACP
10:45 AM
Vancomycin-Resistant Enterococcus Alters the Gastrointestinal Microbiome in Critically Ill Patients
Edward Cuaresma, MD; Monica Laszkowska, MD; Stephania Stump, BS; Dagmara Moscoso, BS; David Chong, MD; Daniel Freedberg, MD, MS
11:00 AM
Impact of Antibiotics Used to Treat Community Acquired Pneumonia on the Gut Microbiome and Resistome in Healthy Volunteers
Winston Anthony, BS; Bin Wang, MS; Candice Cass, AA; Tiffany Hink, BA; Kimberly Reske, MPH; Sondra Seiler, BA; Erik R. Dubberke, MD, MSPH; Carey-Ann D. Burnham, PhD; Gautam Dantas, PhD; Jennie Kwon, DO, MSCI
11:15 AM
Ridinilazole (RDZ) for Clostridium difficile infection (CDI): Correlation of In Vitro Spectrum of Activity with Human Gut Microbiome Profiles from a Phase 2 Clinical Trial
Richard Vickers, PhD; Ellie J C Goldstein, MD, FIDSA, FSHEA; Diane Citron, B.Sc.; David Snydman, MD, FIDSA; Cheleste M. Thorpe, MD; Anne V. Kane, MD

CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.